Mendelian genetics of human susceptibility to fungal infection

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 6, 2014, Pages

  Lionakis, Michail S ^a   Netea, Mihai G ^b   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DECTIN 1; GAMMA INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; PROTEIN KINASE TYK2; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE 4; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG; GENETIC MARKER;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE DISORDER; CHRONIC GRANULOMATOUS DISEASE; GENE MUTATION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HUMAN; HYPER IGE SYNDROME; HYPOHIDROTIC ECTODERMAL DYSPLASIA; IMMUNE DEFICIENCY; MYCOSIS; MYELOPEROXIDASE DEFICIENCY; PHAGOCYTE DYSFUNCTION; SIGNAL TRANSDUCTION; DISEASE PREDISPOSITION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MUTATION;

FUNGI;

DISEASE SUSCEPTIBILITY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; MYCOSES; SIGNAL TRANSDUCTION;

EID: 84920646924     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a019638     Document Type: Article

References (120)

1. Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schäffer AA, Gertz EM, Schambach A, Kreipe HH, Pfeifer D, et al. 2012. The phenotype of human STK4 deficiency. Blood 119: 3450-3457.
2. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. 1990. Clinical variation of autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322: 1829-1836.
3. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, et al. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395-1401.
4. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N. 1999. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67: 1828-1836.
5. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291-300.
6. Bianchi M, Hakkim A, Brinkmann V, Siler U, Seger RA, Zychlinsky A, Reichenbach J. 2009. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 114: 2619-2622.
7. Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, McGovern N, Jardine L, Pagan S, Dimmick I, Chua I, et al. 2011. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208: 227-234.
8. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320: 1731-1735.
9. Björses P, Aaltonen J, Vikman A, Perheentupa J, Ben-Zion G, Chiumello G, Dahl N, Heideman P, Hoorweg-Nijman JJ, Mathivon L, et al. 1996. Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Genet 59: 879-886.
10. Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, Belkadi A, Picard C, Abel L, Fieschi C, et al. 2013. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 39: 676-686.
11. Brown GD. 2011. Innate antifungal immunity: The key role of phagocytes. Annu Rev Immunol 29: 1-21.
12. Brown GD, Denning DW, Levitz SM. 2012a. Tackling human fungal infections. Science 336: 647.
13. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012b. Hidden killers: Human fungal infections. Sci Transl Med 4: p165rv13.
14. Cech P, Papathanassiou A, Boreux G, Roth P, Miescher PA. 1979. Hereditary myeloperoxidase deficiency. Blood 53: 403-411.
15. Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC, Holland SM, Turner ML. 2012. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 148: 79-84.
16. Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA, Edgerton M, Gaffen SL. 2011. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol 4: 448-455.
17. Courtois G, Smahi A, Reichenbach J, Döffinger R, Cancrini C, Bonnet M, Puel A, Chable-Bessia C, Yamaoka S, Feinberg J, et al. 2003. A hypermorphic Ik-Ba mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T-cell immunodeficiency. J Clin Invest 112: 1108-1115.
18. Cuellar-Rodriguez J, Gea-Banacloche J, Freeman AF, Hsu AP, Zerbe CS, Calvo KR, Wilder J, Kurlander R, Olivier KN, Holland SM, et al. 2011. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood 118: 3715-3720.
19. Davis SD, Schaller J, Wedgwood RJ. 1966. Job’s syndrome. Recurrent, “cold,” staphylococcal abscesses. Lancet 1: 1013-1015.
20. de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Jannière L, et al. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 205: 1543-1550.
21. de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, Al-Muhsen S, Jannière L, Rose Y, de Suremain M, et al. 2010. Revisiting human IL-12Rb1 deficiency: A survey of 141 patients from 30 countries. Medicine (Baltimore) 89: 381-402.
22. Diamond RD, Clark RA. 1982. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 38: 487-495.
23. Dickinson RE, Griffin H, Bigley V, Reynard LN, Hussain R, Haniffa M, Lakey JH, Rahman T, Wang XN, McGovern N, et al. 2011. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118: 2656-2658.
24. Döffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, et al. 2001. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kB signaling. Nat Genet 27: 277-285.
25. Dorhoi A, Desel C, Yeremeev V, Pradl L, Brinkmann V, Mollenkopf HJ, Hanke K, Gross O, Ruland J, Kaufmann SH. 2010. The adaptor molecule CARD9 is essential for tuberculosis control. J Exp Med 207: 777-792.
26. Drewniak A, Gazendam RP, Tool AT, van Houdt M, Jansen MH, van Hamme JL, van Leeuwen EM, Roos D, Scalais E, de Beaufort C, et al. 2013. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121: 2385-2392.
27. Drummond RA, Saijo S, Iwakura Y, Brown GD. 2011. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 41: 276-281.
28. Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I, et al. 2009. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 124: 1289-1302.
29. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C, et al. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361: 1760-1767.
30. Freeman AF, Davis J, Anderson VL, Barson W, Darnell DN, Puck JM, Holland SM. 2006. Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics 118: e1271-1275.
31. Gaffen SL. 2011. Recent advances in the IL-17 cytokine family. Curr Opin Immunol 23: 613-619.
32. Gardner JM, Metzger TC, McMahon EJ, Au-Yeung BB, Krawisz AK, Lu W, Price JD, Johannes KP, Satpathy AT, Murphy KM, et al. 2013. Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4þ T cells. Immunity 39: 560-572.
33. Gavanescu I, Benoist C, Mathis D. 2008. B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: A therapeutic approach for APECED patients. Proc Natl Acad Sci 105: 13009-13014.
34. Glocker EO, Hennigs A, Nabavi M, Schäffer AA, Woellner C, Salzer U, Pfeifer D, Veelken H, Warnatz K, Tahami F, et al. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361: 1727-1735.
35. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O’Connell AC, Puck JM. 1999. Hyper-IgE syndrome with recurrent infections—An autosomal dominant multisystem disorder. N Engl J Med 340: 692-702.
36. Grimbacher B, Holland SM, Puck JM. 2005. Hyper-IgE syndromes. Immunol Rev 203: 244-250.
37. Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, Babic M, Lin M, Carmagnac A, Lee YK, et al. 2011. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 43: 1012-1017.
38. Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, Fortin A, Haniffa M, Ceron-Gutierrez L, Bacon CM, et al. 2011. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 365: 127-138.
39. Harada Y, Tanaka Y, Terasawa M, Pieczyk M, Habiro K, Katakai T, Hanawa-Suetsugu K, Kukimoto-Niino M, Nishizaki T, Shirouzu M, et al. 2012. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood 119: 4451-4461.
40. Heino M, Scott HS, Chen Q, Peterson P, Mäebpää U, Papasavvas MP, Mittaz L, Barras C, Rossier C, Chrousos GP, et al. 1999. Mutation analyses of North American APS-1 patients. Hum Mutat 13: 69-74.
41. Hernández-Santos N, Gaffen SL. 2012. Th17 cells in immunity to Candida albicans. Cell Host Microbe 11: 425-435.
42. Holland SM. 2013. Chronic granulomatous disease. Hematol Oncol Clin North Am 27: 89-99.
43. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, et al. 2007. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357: 1608-1619.
44. Hsu YM, Zhang Y, You Y, Wang D, Li H, Duramad O, Qin XF, Dong C, Lin X. 2007. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol 8: 198-205.
45. Hsu AP, Davis J, Puck JM, Holland SM, Freeman AF. 2010. Autosomal dominant hyper IgE syndrome. In GeneReviews (ed. Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K). University of Washington, Seattle.
46. Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, et al. 2011. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118: 2653-2655.
47. Hsu AP, Johnson KD, Falcone EL, Sanalkumar R, Sanchez L, Hickstein DD, Cuellar-Rodriguez J, Lemieux JE, Zerbe CS, Bresnick EH, et al. 2013a. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 121: 3830-3837.
48. Hsu AP, Sowerwine KJ, Lawrence MG, Davis J, Henderson CJ, Zarember KA, Garofalo M, Gallin JI, Kuhns DB, Heller T, et al. 2013b. Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism. J Allergy Clin Immunol 131: 1586-1593.
49. Jabara HH, Ohsumi T, Chou J, Massaad MJ, Benson H, Megarbane A, Chouery E, Mikhael R, Gorka O, Gewies A, et al. 2013. A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency. J Allergy Clin Immunol 132: 151-158.
50. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. 2001. Specific missense mutations in NEMO result in hyperIgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2: 223-228.
51. Jhingran A, Mar KB, Kumasaka DK, Knoblaugh SE, Ngo LY, Segal BH, Iwakura Y, Lowell CA, Hamerman JA, Lin X, et al. 2012. Tracing conidial fate and measuring host cell antifungal activity using a reporter of microbial viability in the lung. Cell Rep 2: 1762-1773.
52. Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H, Camcioglu Y, Cokugras H, Somer A, Kutukculer N, et al. 2009. Defects along the TH17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol 124: 342-348.
53. Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, Kreins AY, Grant AV, Abel L, Casanova JL. 2012. A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome. J Pediatr 160: 1055-1057.
54. Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, et al. 2010. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 207: 299-308.
55. Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, Uzel G, DeRavin SS, Priel DA, Soule BP, et al. 2010. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363: 2600-2610.
56. Lanternier F, Pathan S, Vincent QB, Liu L, Cypowyj S, Prando C, Migaud M, Taibi L, Ammar-Khodja A, Boudghene Stambouli O, et al. 2013. Deep dermatophytosis and inherited CARD9 deficiency. N Engl J Med 369: 1704-1714.
57. Lehrer RI, Cline MJ. 1969. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: The role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48: 1478-1488.
58. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, et al. 2007. Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8: 630-638.
59. LeibundGut-Landmann S, Wuthrich M, Hohl TM. 2012. Immunity to fungi. Curr Opin Immunol 24: 449-458.
60. Lindh E, Brännstrom J, Jones P, Wermeling F, Hässler S, Betterle C, Garty BZ, Stridsberg M, Herrmann B, Karlsson MC, et al. 2013. Autoimmunity and cystatin SA1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome type 1. J Autoimmun 42: 1-6.
61. Lionakis MS, Swamydas M, Fischer BG, Plantinga TS, Johnson MD, Jaeger M, Green NM, Masedunskas A, Weigert R, Mikelis C, et al. 2013. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J Clin Invest 123: 5035-5051.
62. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, et al. 2011. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208: 1635-1648.
63. Mathis D, Benoist C. 2009. Aire. Annu Rev Immunol 27: 287-312.
64. Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, Furcas M, Rosatelli MC, Cao A, Congia M. 2012. Autoimmune polyendocrine syndrome type 1: An extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 97: 1114-1124.
65. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, et al. 2008. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452: 773-776.
66. Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, et al. 2006. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25: 745-755.
67. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, et al. 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448: 1058-1062.
68. Minegishi Y, Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, Agematsu K, Yamada M, Kawamura N, Ariga T, et al. 2009. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 206: 1291-1301.
69. Moraes-Vasconcelos D, Grumach AS, Yamaguti A, Andrade ME, Fieschi C, de Beaucoudrey L, Casanova JL, Duarte AJ. 2005. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the b1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis 41: 31-37.
70. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. 1997. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 185: 207-218.
71. Nauseef WM, Root RK, Malech HL. 1983. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest 71: 1297-1307.
72. Nehme NT, Pachlopnik Schmid J, Debeurme F, André-Schmutz I, Lim A, Nitschke P, Rieux-Laucat F, Lutz P, Picard C, Mahlaoui N, et al. 2012. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 119: 3458-3468.
73. Netea MG, Brown GD, Kullberg BJ, Gow NA. 2008. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6: 67-78.
74. Notarangelo LD. 2010. Primary immunodeficiencies. J Allergy Clin Immunol 125: S182-194.
75. Oh J, Freeman AF, NISC Comparative Sequencing Program, Park M, Sokolic R, Candotti F, Holland SM, Segre JA, Kong HH. 2013. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res 23: 2103-2114.
76. O’Shea JJ, Holland SM, Staudt LM. 2013. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 368: 161-170.
77. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, et al. 2011. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 43: 929-931.
78. Picard C, Casanova JL, Puel A. 2011. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or Ik-Ba deficiency. Clin Microbiol Rev 24: 490-497.
79. Popler J, Alimohammadi M, Kämpe O, Dalin F, Dishop MK, Barker JM, Moriarty-Kelsey M, Soep JB, Deterding RR. 2012. Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatr Pulmonol 47: 84-87.
80. Puel A, Döffinger R, Natividad A, Chrabieh M, BarcenasMorales G, Picard C, Cobat A, Ouachée-Chardin M, Toulon A, Bustamante J, et al. 2010. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207: 291-297.
81. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65-68.
82. Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J. 2007. Oral and oesophageal squamous cell carcinoma—A complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol 43: 607-613.
83. Reeves EP, Lu H, Jacobs HL, Messina CG, Bolsover S, Gabella G, Potma EO, Warley A, Roes J, Segal AW. 2002. Killing activity of neutrophils is mediated through activation of proteases by Kþ flux. Nature 416: 291-297.
84. Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M, Davis J, Belohradsky BH, Grimbacher B. 2004. Autosomal recessive hyperimmunoglobulin E syndrome: A distinct disease entity. J Pediatr 144: 93-99.
85. Rezai MS, Khotael G, Kheirkhah M, Hedayat T, Geramishoar M, Mahjoub F. 2008. Cryptococcosis and deficiency of interleukin-12r. Pediatr Infect Dis J 27: 673.
86. Romani L, Fallarino F, De Luca A, Montagnoli C, D’Angelo C, Zelante T, Vacca C, Bistoni F, Fioretti MC, Grohmann U, et al. 2008. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
87. Rosenzweig SD, Holland SM. 2005. Defects in the interferon-g and interleukin-12 pathways. Immunol Rev 203: 38-47.
88. Ruusala A, Aspenström P. 2004. Isolation and characterisation of DOCK8, a member of the DOCK180-related regulators of cell morphology. FEBS Lett 572: 159-166.
89. Salt BH, Niemela JE, Pandey R, Hanson EP, Deering RP, Quinones R, Jain A, Orange JS, Gelfand EW. 2008. IKBKG (nuclear factor-kB essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function. J Allergy Clin Immunol 121: 976-982.
90. Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, Chandrasekaran P, Rosen LB, Carvalho DS, Ding L, et al. 2013. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J Allergy Clin Immunol 131: 1624-1634.
91. Schimke LF, Rieber N, Rylaarsdam S, Cabral-Marques O, Hubbard N, Puel A, Kallmann L, Sombke SA, Notheis G, Schwarz HP, et al. 2013. A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy. J Clin Immunol 33: 1088-1099.
92. Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. 1998. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 77: 345-354.
93. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. 2000. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79: 170-200.
94. Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM. 2005. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 40: 1684-1688.
95. Siddiqui S, Anderson VL, Hilligoss DM, Abinun M, Kuijpers TW, Masur H, Witebsky FG, Shea YR, Gallin JI, Malech HL, et al. 2007. Fulminant mulch pneumonitis: An emergency presentation of chronic granulomatous disease. Clin Infect Dis 45: 673-681.
96. Smeekens SP, Plantinga TS, van de Veerdonk FL, Heinhuis B, Hoischen A, Joosten LA, Arkwright PD, Gennery A, Kullberg BJ, Veltman JA, et al. 2011. STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. PLoS ONE 6: e29248.
97. Smeekens SP, Huttenhower C, Riza A, van de Veerdonk FL, Zeeuwen PL, Schalkwijk J, van der Meer JW, Xavier RJ, Netea MG, Gevers D. 2013. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses. J Innate Immun 6: 253-262.
98. Sobel JD. 2007. Vulvovaginal candidosis. Lancet 369: 1961-1971.
99. Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, et al. 2014. GATA2 deficiency: A protean disorder of hematopoiesis, lymphatics and immunity. Blood 123: 809-821.
100. Tarr PE, Sneller MC, Mechanic LJ, Economides A, Eger CM, Strober W, Cunningham-Rundles C, Lucey DR. 2001. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) 80: 123-133.
101. Ulinski T, Perrin L, Morris M, Houang M, Cabrol S, Grapin C, Chabbert-Buffet N, Bensman A, Deschênes G, Giurgea I. 2006. Autoimmune polyendocrinopathy-candidiasisectodermal dystrophy syndrome with renal failure: Impact of posttransplant immunosuppression on disease activity. J Clin Endocrinol Metab 91: 192-195.
102. Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, Noel RJ, Verbsky JW, Freeman AF, Janssen E, et al. 2013. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol 131: 1611-1123.
103. van de Veerdonk FL, Plantinga TS, Smeekens SP, Joosten LA, Gilissen C, Arts P, Rosentul DC, Carmichael AJ, Smitsvan der Graaf CA, Kullberg BJ, et al. 2011. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365: 54-61.
104. Vinh DC, Freeman AF, Shea YR, Malech HL, Abinun M, Weinberg GA, Holland SM. 2009a. Mucormycosis in chronic granulomatous disease: Association with iatrogenic immunosuppression. J Allergy Clin Immunol 123: 1411-1413.
105. Vinh DC, Masannat F, Dzioba RB, Galgiani JN, Holland SM. 2009b. Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-g receptor 1 deficiency. Clin Infect Dis 49: 62-65.
106. Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, Olivier KN, Spalding C, Hughes S, Pittaluga S, Raffeld M, et al. 2010a. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 115: 1519-1529.
107. Vinh DC, Sugui JA, Hsu AP, Freeman AF, Holland SM. 2010b. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol 125: 1389-1390.
108. Vinh DC, Schwartz B, Hsu AP, Miranda DJ, Valdez PA, Fink D, Lau KP, Long-Priel D, Kuhns DB, Uzel G, et al. 2011. Interleukin-12 receptor b1 deficiency predisposing to disseminated coccidioidomycosis. Clin Infect Dis 52: 99-102.
109. von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321: 691-696.
110. Wang X, Lin Z, Gao L, Wang A, Wan Z, Chen W, Yang Y, Li R. 2013a. Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis. J Allergy Clin Immunol 131: 1242-1243.
111. Wang X, Wang W, Lin Z, Wang X, Li T, Yu J, Liu W, Tong Z, Xu Y, Zhang J, et al. 2013b. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies. J Allergy Clin Immunol in press.
112. Wildbaum G, Shahar E, Katz R, Karin N, Etzioni A, Pollack S. 2013. Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: Complete clinical remission with restoration of IL-17 secretion. J Allergy Clin Immunol 132: 761-764.
113. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, et al. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79: 155-169.
114. Woellner C, Schäffer AA, Puck JM, Renner ED, Knebel C, Holland SM, Plebani A, Grimbacher B. 2007. The hyper IgE syndrome and mutations in TYK2. Immunity 26: 535.
115. Wu S, Huang J, Dong J, Pan D. 2003. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114: 445-456.
116. Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI. 2007. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol 178: 6367-6373.
117. Zerbe CS, Holland SM. 2005. Disseminated histoplasmosis in persons with interferon-g receptor 1 deficiency. Clin Infect Dis 41: 38-41.
118. Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, Matthews HF, Davis J, Turner ML, Uzel G, et al. 2009. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361: 2046-2055.
119. Zhu LL, Zhao XQ, Jiang C, You Y, Chen XP, Jiang YY, Jia XM, Lin X. 2013. C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity 39: 324-334.
120. Zlotogora J, Shapiro MS. 1992. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 29: 824-826.